清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Abstract 2629: A novel ADAM9 ADC with robust anti-tumor efficacy and remarkable preclinical safety profile.

作者
Ruirui Sui,You Lü,Furong Gao,C. Xu,Jiangbo Song,Guoping Jiang,Liuge Gu,Teddy Tat Chi Yang,Ying Lei,Li Tong,Fei Peng
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:86 (7_Supplement): 2629-2629
标识
DOI:10.1158/1538-7445.am2026-2629
摘要

Abstract ADAM9 (A Disintegrin And Metalloproteinase 9) is a transmembrane metalloproteinase overexpressed in a wide range of solid tumors, where it promotes tumor progression, metastasis, and poor prognosis. Internal immunohistochemistry analysis confirmed ADAM9 expressed at very low levels in most normal tissues, significant ADAM9 upregulation in tumor tissues, makes it a highly attractive and viable target for antibody-drug conjugate (ADC) development. An affinity optimized, humanized monoclonal antibody (HC031) was generated against human ADAM9. HC031 cross reacts with cyno ADAM9 with similar affinity. HC031 exhibited specific binding to human ADAM9 with no detectable binding to other ADAM family isoforms. HC031 selectively binds to membrane form of ADAM9 but not to short soluble ADAM9 predicting a regular pharmacokinetic profile unimpeded by soluble ADAM9. Furthermore, HC031 binding is partially dependent of bivalent cation, which may contribute to an improved safety profile. HC031 ADC was generated through conjugation with a novel, proprietary cytotoxic payload (camptothecin derivatives) via a highly stable linker. The resulting ADC demonstrated potent, target-specific cell killing in vitro and induced robust and sustained tumor regression in multiple xenograft models. Exploratory toxicology studies in non-human primates revealed an exceptionally maximum tolerated dose (MTD) of 120 mg/kg. No drug-related severe adverse events or significant abnormalities in hematological, biochemical, or coagulation parameters were observed. HC031 ADC exhibited favorable and dose-proportional PK profiles, with extended exposure of the intact ADC. Critically, the linker-payload demonstrated superior plasma stability.HC031 ADC drives potent anti-tumor activity in vitro and in vivo. Its exceptional stability in circulation and remarkable preclinical safety profile in NHPs predicts a significantly broader therapeutic window compared to existing ADAM9 ADCs. Citation Format: Ruirui Sui, Yin Lu, Furong Gao, Chen Xu, Jiangbo Song, Guoping Jiang, Liuge Gu, Teddy Yang, Ying Lei, Li Tong, Fei Peng, . A novel ADAM9 ADC with robust anti-tumor efficacy and remarkable preclinical safety profile [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2629.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wsj完成签到 ,获得积分10
1秒前
Tardes发布了新的文献求助10
2秒前
ss完成签到,获得积分10
5秒前
甜美的梦芝完成签到,获得积分10
7秒前
西瓜柠檬可乐完成签到 ,获得积分10
22秒前
李煜琛完成签到 ,获得积分10
30秒前
悦耳的竺完成签到 ,获得积分10
30秒前
搜集达人的应助被冲冲冲采纳,获得10
31秒前
大力的安阳完成签到 ,获得积分10
34秒前
无花果的应助被ZLPY采纳,获得30
34秒前
41秒前
41秒前
刘亚梅完成签到 ,获得积分10
44秒前
醉熏的小凡完成签到,获得积分10
46秒前
冲冲冲发布了新的文献求助10
47秒前
apt完成签到 ,获得积分10
51秒前
57秒前
忧伤的白秋完成签到,获得积分10
59秒前
1分钟前
lx完成签到 ,获得积分10
1分钟前
天天快乐的应助被hilufite采纳,获得10
1分钟前
nhzz2023完成签到 ,获得积分10
1分钟前
和谐如彤完成签到,获得积分10
1分钟前
nanjing01完成签到 ,获得积分10
1分钟前
如泣草芥完成签到,获得积分10
1分钟前
Jessie完成签到,获得积分10
1分钟前
RZH发布了新的文献求助50
1分钟前
hy发布了新的文献求助10
1分钟前
笙歌完成签到 ,获得积分10
1分钟前
点点完成签到 ,获得积分10
1分钟前
细胞呵呵完成签到 ,获得积分10
1分钟前
cc发布了新的文献求助10
1分钟前
1分钟前
长孙烙完成签到 ,获得积分10
1分钟前
菜鸟学习完成签到 ,获得积分10
2分钟前
wayne完成签到 ,获得积分0
2分钟前
junio完成签到 ,获得积分10
2分钟前
威武的迎蓉完成签到,获得积分10
2分钟前
慎独而已完成签到,获得积分10
2分钟前
gzhy完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173230
求助须知:如何正确求助?哪些是违规求助? 9565593
关于积分的说明 21780525
捐赠科研通 7767429
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697